Determination of methotrexate, several pteridines, and creatinine in human urine, previous oxidation with potassium permanganate, using HPLC with photometric and fluorimetric serial detection.
A novel HPLC method, using UV and fluorimetric serial detection, for the simultaneous determination of methotrexate (MTX), five disease marker pteridines, and the reference metabolic subproduct creatinine (CREA) in human urine was established. A previous oxidation process using 10(-3) M KMnO4 (pH 5.0) and 35min of oxidation time was necessary to transform the analytes in the highly fluorescent pteridinic rings. CREA was not affected by the oxidative medium. Using Tris-HCl/NaCl buffer solution (pH 6.6) as mobile phase, MTX and the assayed pteridines were monitored by fluorescence at lambda(em) = 444 nm and lambda(ex) = 280 nm and creatinine was monitored by absorption measurements at lambda(abs) = 230 nm. All components were well resolved in approximately 7 min. Detection limits, according the criteria of Clayton and co-workers, were 10 ng ml(-1) for MTX, less than 1 ng ml(-1) for all of the pteridines, and 4 microg ml(-1) for CREA.
Durán Merás
Isabel
I
Department of Analytical Chemistry, University of Extremadura, 06071 Badajoz, Spain. iduran@unex.es
Espinosa Mansilla
Anunciación
A
Rodríguez Gómez
M José
MJ
D015415:Biomarkers / Q000652:urine; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D003404:Creatinine / Q000652:urine*; D005470:Fluorometry; D006801:Humans; D008727:Methotrexate / Q000737:chemistry / Q000652:urine*; D010084:Oxidation-Reduction; D010783:Photometry; D011196:Potassium Permanganate / Q000737:chemistry; D011621:Pteridines / Q000737:chemistry / Q000652:urine*; D014466:Ultraviolet Rays
D015415:Biomarkers; D011621:Pteridines; D011196:Potassium Permanganate; D003404:Creatinine; D008727:Methotrexate